TransCode TherapeuticsOffering
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
a Co-Founder of TransCode, is recognized nationally and internationally for her ... nanodelivery platform and identified microRNA-10b as a promising therapeutic ... as the president and chief executive officer of Isarna Therapeutics B.V. (“Isarna”), ...
on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and update you on our platform's ongoing offerings. TransCode Therapeutics TransCode is a pre-clinical biopharmaceutical company focused on the discovery, ...
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
Ms. Keith has been a Chief Financial Officer for private and public ... Ms. Keith held a senior accounting role for a public company listed ...
Your Investment Helps Fight Against Deadly Bacteria & Viruses
sclerosis (MS), or who have suffered a stroke or have nerve injuries. ...
is a pioneer in the clinical use of DNA as a therapeutic agent and is the first ...
in the clinical use of DNA as a therapeutic agent and is the first to conduct ...
Convertible note pays 10% per year. Minimum investment $10,000